Ryvu Therapeutics S.A. (RVU)
Market Closed
15 Oct, 02:50 PM
WSE 
zł
17. 44
+0.54
+3.1953%
zł
1.21B Market Cap
- P/E Ratio
- Div Yield
28,966 Volume
0 Eps
zł 16.9
Previous Close Want to track RVU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ryvu Therapeutics S.A. (RVU) Statistics
Valuation metrics
Market Cap 1.21B
Enterprise value 405.76M
Trailing P/E (ttm) -5.48
Forward P/E -
PEG ratio -0.09
Price/Sales (ttm) 6.17
Price/Book (mrq) 12.65
Enterprise Value/Revenue 6.56
Enterprise Value/EBITDA -6.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.33K
Average volume (90 days) 30.04K
Price summary
52-Week low 13.64
52-Week high 31.9
Beta -
50-Day moving average 16.77
200-Day moving average 18.06
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.1%
Operating margin -1.35%
Operational effectiveness
Return on assets -0.37%
Return on equity -1.4%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.84
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.43
Total debt (mrq) -
Total Debt/Equity (mrq) 2.64
Current ratio (mrq) 2.14%
Book value per share (mrq) 1.3
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
